Browsing by Author Kang, Peter

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2014Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trialKefford, Richard (Rick); Boasberg, Peter; Chmielowski, Bartosz; Daud, Adil; Dronca, Roxana; Ebbinghaus, Scot; Elassaiss-Schaap, Jeroen; Gangadhar, Tara C.; Gergich, Kevin; Hamid, Omid; Hodi, F. Stephen; Hwu, Wen-Jen; Iannone, Robert; Joseph, Richard W.; Joshua, Anthony M.; Kang, Peter; Li, Xiaoyun; Mateus, Christine; Patnaik, Amita; Postow, Michael; Ribas, Antoni; Robert, Caroline; Weber, Jeffrey; Wolchok, Jedd D.; Zarour, Hassane; Western Clinical School: Westmead Millennium InstituteAnti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial, The Lancet, vol.384, 9948, 2014,pp 1109-1117
2007Distinctive patterns of microRNA expression in primary muscular disorders.North, Kathryn; Amato, Anthony; Beggs, Alan H.; Eisenberg, Iris; Eran, Alal; Flanigan, Kevin M.; Kang, Peter; Kohane, Isaac S.; Kunkel, Louis M.; Lamperti, Costanza; Lidov, Hart; Mitrani-Rosenbaum, Stella; Moggio, Maurizio; Neely, Lori A.; Nishino, Ichizo; Whitney, Duncan; Children's Hospital Westmead: Paediatrics & Child HealthDistinctive patterns of microRNA expression in primary muscular disorders., National Academy of Sciences 2005, vol.104,(43),2007,pp 17016-17021